GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Market Cap

Oncodesign Precision Medicine (XPAR:ALOPM) Market Cap : €7.72 Mil (As of Apr. 09, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Oncodesign Precision Medicine's share price for the quarter that ended in Dec. 2023 was €1.81. Oncodesign Precision Medicine's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 16.64 Mil. Therefore, Oncodesign Precision Medicine's market cap for the quarter that ended in Dec. 2023 was €30.11 Mil.

Oncodesign Precision Medicine's quarterly market cap declined from Dec. 2022 (€28.20 Mil) to Jun. 2023 (€22.28 Mil) but then increased from Jun. 2023 (€22.28 Mil) to Dec. 2023 (€30.11 Mil).

Oncodesign Precision Medicine's annual market cap increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€28.20 Mil) and increased from Dec. 2022 (€28.20 Mil) to Dec. 2023 (€30.11 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Oncodesign Precision Medicine's Enterprise Value for Today is €6.21 Mil.

Oncodesign Precision Medicine Market Cap Historical Data

The historical data trend for Oncodesign Precision Medicine's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Market Cap Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Market Cap
- - 28.20 30.11

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial - 28.20 22.28 30.11 17.26

Competitive Comparison of Oncodesign Precision Medicine's Market Cap

For the Biotechnology subindustry, Oncodesign Precision Medicine's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Market Cap distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Market Cap falls into.


;
;

Oncodesign Precision Medicine Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Oncodesign Precision Medicine's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€1.81*16.635
=€30.11

Oncodesign Precision Medicine's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€1.81*16.635
=€30.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncodesign Precision Medicine  (XPAR:ALOPM) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Oncodesign Precision Medicine Market Cap Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Market Cap
Comparable Companies
XPAR:ALTAO XPAR:ALTME XPAR:ALVET XPAR:ALVIO XPAR:ALINT XPAR:ALTHX XPAR:ALBPS XPAR:ALPAT XPAR:GNRO XPAR:ALMDP VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ZR8:Germany
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Website
https://www.opm.oncodesign.com
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines